Chugai Pharmaceutical Co., Ltd.
4519Pharmaceuticals
¥6,653.00+0.59%As of Oct 29vs prior close
- Market cap
- $69.3B
- P/E (TTM)
- 21.7×
- P/E (FY1)
- 21.7×
- From 52W high
- −35.80%
- EPS (LTM)
- ¥290.72
- Revenue (LTM)
- ¥1.3T
- Net margin
- 35.61%
- Dividend yield
- 3.20%
Nomior Score
44
Steady ProfileBottom 36% of the scored universe
Growth47
Quality64
Value34
Momentum34
Resilience57
Growth
−0.05%revenue a year over 3 fiscal years
YE22 ¥1.3TLTM ¥1.3T
Connections
Revenue to profitYE25
35% of revenue became net profit, up 1 pt on a year.